A novel relationship between plasma kininogen and rheumatoid

Area of Science:

• Biochemistry
• Rheumatology
• Pharmacology

Background:

• Elevated plasma kininogen is observed in active rheumatoid disease compared to healthy individuals.
• Rheumatoid disease is a chronic inflammatory disorder affecting joints.

Purpose of the Study:

• To investigate the effect of non-steroidal anti-inflammatory drugs (NSAIDs) on plasma kininogen levels in rheumatoid disease.
• To determine the correlation between plasma kininogen reduction and clinical improvement.

Main Methods:

• Measurement of plasma kininogen levels in untreated rheumatoid disease patients and healthy controls.
• Administration of oral indomethacin or aspirin to rheumatoid disease patients.
• Monitoring of plasma kininogen levels and clinical inflammatory indices post-drug administration.

Main Results:

• Plasma kininogen levels were over twice as high in active rheumatoid disease patients compared to controls.
• Indomethacin and aspirin treatment rapidly decreased plasma kininogen levels within 1-2 hours.
• The reduction in plasma kininogen paralleled a decrease in clinical signs of inflammation.
• Indomethacin did not affect plasma kininogen in healthy volunteers, ruling out non-specific effects.

Conclusions:

• Plasma kininogen is a potential biomarker for active rheumatoid disease.
• NSAIDs like indomethacin and aspirin effectively reduce plasma kininogen levels in rheumatoid disease.
• The rapid reduction in plasma kininogen suggests a direct drug effect linked to anti-inflammatory action.